A U.S. appeals court on October 16 denied Kenvue’s request to reconsider a July ruling that revived about 500 lawsuits. [1, 2, 3] The cases allege prenatal exposure to Tylenol, Kenvue’s popular painkiller, is linked to autism and ADHD in children. [5, 6]
The court upheld a finding that a lower court improperly excluded expert testimony supporting the plaintiffs’ claims. [2, 5] The decision allows the cases to proceed but does not establish that Tylenol causes the conditions.
Kenvue maintains that Tylenol is safe and said it plans to ask the U.S. Supreme Court to review the case. [5]